Audit in process? Call the number on your audit letter to get options.
Close
Valuable and timely information on drug therapy issues impacting today's health care and pharmacy environment.
June 1, 2021, Hikma - Mylan, Glenmark and Camber/Hetero launched AB-rated generic versions of Eisai’s Banzel (rufinamide) 200 mg and 400 mg tablets.
Download PDF
Return to publications
